Showing results (71-80 of 118) with videos related to

Sort By:
Pageof 12
International Journal of Cancer|March 1, 1996
Spatial heterogeneity of tumour blood flow modification induced by angiotensin II: relationship to receptor distributionG M Tozer, K M Shaffi, V E Prise, et al.
Reviews of Infectious Diseases|January 1, 1991
Risk factors associated with chronic fatigue syndrome in a cluster of pediatric casesK M Bell, D Cookfair, D S Bell, et al.
Journal of Cardiovascular Pharmacology|January 1, 1995
Effect of endothelin-1 and sarafotoxin S6c on blood flow in a rat tumorK M Bell, V E Prise, D J Chaplin, et al.
The British Journal of Cancer. Supplement|July 1, 1996
Tumour blood flow modification by endothelin-related peptides in the rat HSN fibrosarcomaK M Bell, V E Prise, D J Chaplin, et al.
Journal of Medicinal Chemistry|September 1, 2000
3-Deoxyclocinnamox: the first high-affinity, nonpeptide mu-opioid antagonist lacking a phenolic hydroxyl groupI Derrick, C L Neilan, J Andes, et al.
Seminars in Radiation Oncology|June 20, 1998
Modification of tumor blood flow: current status and future directionsD J Chaplin, S A Hill, K M Bell, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 17, 2000
BU48: a novel buprenorphine analog that exhibits delta-opioid-mediated convulsions but not delta-opioid-mediated antinociception in miceD C Broom, L Guo, A Coop, et al.
Journal of Molecular and Cellular Cardiology|December 13, 2000
An immortalized myocyte cell line, HL-1, expresses a functional delta -opioid receptorC L Neilan, E Kenyon, M A Kovach, et al.
The Journal of Bone and Joint Surgery. British Volume|May 1, 1992
Primary knee arthroplasty for distal femoral fractures in elderly patientsK M Bell, A J Johnstone, C M Court-Brown, et al.
Pageof 12